{"entity":{"type":"insider","cik":"0001664697","url":"/insider/0001664697","json_url":"/insider/0001664697.json","name":"White Daniel H.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":8,"first":"2016-06-07","last":"2018-06-04","span_basis":"filed_date"},"name_variants":[{"name":"White Daniel H.","source":"filing","n_filings":8,"first_seen":"2016-06-07","last_seen":"2018-06-04"}],"transactions":[{"id":5964774,"accession":"0001209191-18-035387","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-035387","line_url":"/filing/0001209191-18-035387#line-2","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11000.0,"shares_display":"11,000","price_per_share":9.07,"price_display":"9.07","price_state":"stated","total_value":99770.0,"total_display":"99,770.00","shares_owned_after":483335.0,"shares_owned_after_display":"483,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-04","filed_date":"2018-06-04","scope":"insider"},{"id":4907697,"accession":"0001209191-17-057698","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-057698","line_url":"/filing/0001209191-17-057698#line-4","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":7.81,"price_display":"7.81","price_state":"stated","total_value":28116.0,"total_display":"28,116.00","shares_owned_after":474335.0,"shares_owned_after_display":"474,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-19","filed_date":"2017-10-23","scope":"insider"},{"id":4907689,"accession":"0001209191-17-057698","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-057698","line_url":"/filing/0001209191-17-057698#line-3","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.81,"price_display":"7.81","price_state":"stated","total_value":3124.0,"total_display":"3,124.00","shares_owned_after":35309.0,"shares_owned_after_display":"35,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-19","filed_date":"2017-10-23","scope":"insider"},{"id":4907684,"accession":"0001209191-17-057698","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-057698","line_url":"/filing/0001209191-17-057698#line-2","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":7.82,"price_display":"7.82","price_state":"stated","total_value":28152.0,"total_display":"28,152.00","shares_owned_after":477935.0,"shares_owned_after_display":"477,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-18","filed_date":"2017-10-23","scope":"insider"},{"id":4907681,"accession":"0001209191-17-057698","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-057698","line_url":"/filing/0001209191-17-057698#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.82,"price_display":"7.82","price_state":"stated","total_value":3128.0,"total_display":"3,128.00","shares_owned_after":35709.0,"shares_owned_after_display":"35,709","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-18","filed_date":"2017-10-23","scope":"insider"},{"id":4111196,"accession":"0001209191-17-052218","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-052218","line_url":"/filing/0001209191-17-052218#line-4","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5400.0,"shares_display":"5,400","price_per_share":7.63,"price_display":"7.63","price_state":"stated","total_value":41202.0,"total_display":"41,202.00","shares_owned_after":481535.0,"shares_owned_after_display":"481,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-08","filed_date":"2017-09-11","scope":"insider"},{"id":4111192,"accession":"0001209191-17-052218","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-052218","line_url":"/filing/0001209191-17-052218#line-3","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":7.63,"price_display":"7.63","price_state":"stated","total_value":4578.0,"total_display":"4,578.00","shares_owned_after":36109.0,"shares_owned_after_display":"36,109","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-08","filed_date":"2017-09-11","scope":"insider"},{"id":4111189,"accession":"0001209191-17-052218","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-052218","line_url":"/filing/0001209191-17-052218#line-2","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":7.53,"price_display":"7.53","price_state":"stated","total_value":67770.0,"total_display":"67,770.00","shares_owned_after":486935.0,"shares_owned_after_display":"486,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-07","filed_date":"2017-09-11","scope":"insider"},{"id":4111184,"accession":"0001209191-17-052218","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-052218","line_url":"/filing/0001209191-17-052218#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":7.53,"price_display":"7.53","price_state":"stated","total_value":7530.0,"total_display":"7,530.00","shares_owned_after":36709.0,"shares_owned_after_display":"36,709","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-07","filed_date":"2017-09-11","scope":"insider"},{"id":4784349,"accession":"0001209191-17-045979","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-045979","line_url":"/filing/0001209191-17-045979#line-4","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":9.71,"price_display":"9.71","price_state":"stated","total_value":34956.0,"total_display":"34,956.00","shares_owned_after":496367.0,"shares_owned_after_display":"496,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-21","scope":"insider"},{"id":4784344,"accession":"0001209191-17-045979","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-045979","line_url":"/filing/0001209191-17-045979#line-3","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":9.71,"price_display":"9.71","price_state":"stated","total_value":3884.0,"total_display":"3,884.00","shares_owned_after":37709.0,"shares_owned_after_display":"37,709","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-21","scope":"insider"},{"id":4784341,"accession":"0001209191-17-045979","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-045979","line_url":"/filing/0001209191-17-045979#line-2","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":9.79,"price_display":"9.79","price_state":"stated","total_value":35244.0,"total_display":"35,244.00","shares_owned_after":499967.0,"shares_owned_after_display":"499,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-19","filed_date":"2017-07-21","scope":"insider"},{"id":4784337,"accession":"0001209191-17-045979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-045979","line_url":"/filing/0001209191-17-045979#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":9.79,"price_display":"9.79","price_state":"stated","total_value":3916.0,"total_display":"3,916.00","shares_owned_after":38109.0,"shares_owned_after_display":"38,109","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-19","filed_date":"2017-07-21","scope":"insider"},{"id":4831874,"accession":"0001209191-17-039986","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-039986","line_url":"/filing/0001209191-17-039986#line-4","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":7.99,"price_display":"7.99","price_state":"stated","total_value":28764.0,"total_display":"28,764.00","shares_owned_after":500467.0,"shares_owned_after_display":"500,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-14","filed_date":"2017-06-14","scope":"insider"},{"id":4831872,"accession":"0001209191-17-039986","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-039986","line_url":"/filing/0001209191-17-039986#line-3","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.99,"price_display":"7.99","price_state":"stated","total_value":3196.0,"total_display":"3,196.00","shares_owned_after":38509.0,"shares_owned_after_display":"38,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-14","filed_date":"2017-06-14","scope":"insider"},{"id":4831868,"accession":"0001209191-17-039986","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-039986","line_url":"/filing/0001209191-17-039986#line-2","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":7.78,"price_display":"7.78","price_state":"stated","total_value":28008.0,"total_display":"28,008.00","shares_owned_after":504067.0,"shares_owned_after_display":"504,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-13","filed_date":"2017-06-14","scope":"insider"},{"id":4831864,"accession":"0001209191-17-039986","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-039986","line_url":"/filing/0001209191-17-039986#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.78,"price_display":"7.78","price_state":"stated","total_value":3112.0,"total_display":"3,112.00","shares_owned_after":38909.0,"shares_owned_after_display":"38,909","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-13","filed_date":"2017-06-14","scope":"insider"},{"id":5208330,"accession":"0001209191-17-034011","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-034011","line_url":"/filing/0001209191-17-034011#line-4","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":8.44,"price_display":"8.44","price_state":"stated","total_value":30384.0,"total_display":"30,384.00","shares_owned_after":507667.0,"shares_owned_after_display":"507,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-18","filed_date":"2017-05-19","scope":"insider"},{"id":5208325,"accession":"0001209191-17-034011","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-034011","line_url":"/filing/0001209191-17-034011#line-3","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":8.44,"price_display":"8.44","price_state":"stated","total_value":3376.0,"total_display":"3,376.00","shares_owned_after":39309.0,"shares_owned_after_display":"39,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-18","filed_date":"2017-05-19","scope":"insider"},{"id":5208319,"accession":"0001209191-17-034011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-034011","line_url":"/filing/0001209191-17-034011#line-2","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":8.38,"price_display":"8.38","price_state":"stated","total_value":30168.0,"total_display":"30,168.00","shares_owned_after":511267.0,"shares_owned_after_display":"511,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-17","filed_date":"2017-05-19","scope":"insider"},{"id":5208310,"accession":"0001209191-17-034011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-034011","line_url":"/filing/0001209191-17-034011#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":8.38,"price_display":"8.38","price_state":"stated","total_value":3352.0,"total_display":"3,352.00","shares_owned_after":39709.0,"shares_owned_after_display":"39,709","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-17","filed_date":"2017-05-19","scope":"insider"},{"id":4657367,"accession":"0001209191-17-025761","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-025761","line_url":"/filing/0001209191-17-025761#line-4","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":7.54,"price_display":"7.54","price_state":"stated","total_value":27144.0,"total_display":"27,144.00","shares_owned_after":523617.0,"shares_owned_after_display":"523,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-04","filed_date":"2017-04-05","scope":"insider"},{"id":4657346,"accession":"0001209191-17-025761","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-025761","line_url":"/filing/0001209191-17-025761#line-3","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.54,"price_display":"7.54","price_state":"stated","total_value":3016.0,"total_display":"3,016.00","shares_owned_after":40109.0,"shares_owned_after_display":"40,109","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-04","filed_date":"2017-04-05","scope":"insider"},{"id":4657339,"accession":"0001209191-17-025761","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-025761","line_url":"/filing/0001209191-17-025761#line-2","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":7.56,"price_display":"7.56","price_state":"stated","total_value":27216.0,"total_display":"27,216.00","shares_owned_after":527217.0,"shares_owned_after_display":"527,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-03","filed_date":"2017-04-05","scope":"insider"},{"id":4657334,"accession":"0001209191-17-025761","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-025761","line_url":"/filing/0001209191-17-025761#line-1","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.56,"price_display":"7.56","price_state":"stated","total_value":3024.0,"total_display":"3,024.00","shares_owned_after":40509.0,"shares_owned_after_display":"40,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-03","filed_date":"2017-04-05","scope":"insider"},{"id":2826735,"accession":"0001209191-16-126265","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-126265","line_url":"/filing/0001209191-16-126265#line-2","is_derivative":false,"issuer_cik":"0001539029","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001539029","owner_cik":"0001664697","owner_name":"White Daniel H.","owner_url":"/insider/0001664697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3.0,"shares_display":"3","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":21.0,"total_display":"21.00","shares_owned_after":530817.0,"shares_owned_after_display":"530,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-07","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001539029","name":"Clearside Biomedical, Inc.","url":"/issuer/0001539029","role":"Director, Officer (President and CEO)","n_filings":8,"first_seen":"2016-06-07","last_seen":"2018-06-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001664697","retrieved_at":"2026-08-22T03:21:15+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}